MoneyWorks4Me

Aarey Drugs & Pharma - Quaterly Results

13 Aug 2025 Evaluate
Net sales declined -19.47%  to  Rs. 1022.08 million from Rs. 1269.12 millions.A slim rise of 10.74% was recorded in the Net profit for the quarter ended June 2025 to Rs. 13.71  millions  From Rs. 12.38 millions.OP of the company witnessed a marginal growth to 32.54 millions from 27.53 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1022.08 1269.12 -19.47 1022.08 1269.12 -19.47 4739.43 3956.18 19.80
Other Income 15.52 15.75 -1.46 15.52 15.75 -1.46 98.12 69.65 40.88
PBIDT 32.54 27.53 18.20 32.54 27.53 18.20 120.63 114.17 5.66
Interest 10.38 9.57 8.46 10.38 9.57 8.46 40.17 43.75 -8.18
PBDT 22.16 17.96 23.39 22.16 17.96 23.39 80.46 70.42 14.26
Depreciation 4.88 4.66 4.72 4.88 4.66 4.72 19.45 16.98 14.55
PBT 17.28 13.30 29.92 17.28 13.30 29.92 61.01 53.44 14.17
TAX 3.57 0.92 288.04 3.57 0.92 288.04 20.78 6.59 215.33
Deferred Tax 0.07 -0.08 -187.50 0.07 -0.08 -187.50 1.69 -6.66 -125.38
PAT 13.71 12.38 10.74 13.71 12.38 10.74 40.23 46.85 -14.13
Equity 284.54 280.54 1.43 284.54 280.54 1.43 280.54 280.54 0.00
PBIDTM(%) 3.18 2.17 46.77 3.18 2.17 46.77 2.55 2.89 -11.81
Peers